Lunai Bioworks
LNAI
39 hedge funds and large institutions have $8.54M invested in Lunai Bioworks in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
18% more funds holding
Funds holding: 33 → 39 (+6)
0% less ownership
Funds ownership: 0.07% → 0.06% (-0%)
18% less capital invested
Capital invested by funds: $10.4M → $8.54M (-$1.86M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$168K |
| 2 |
HF
HRT Financial
New York
|
+$165K |
| 3 |
State Street
Boston,
Massachusetts
|
+$150K |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$144K |
| 5 |
Millennium Management
New York
|
+$142K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.42M |
| 2 |
BlackRock
New York
|
-$74.3K |
| 3 |
Jane Street
New York
|
-$53K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$22.1K |
| 5 |
Morgan Stanley
New York
|
-$12K |
LNAI Hedge Fund Activity: Q3 2020 in Review
39 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2020, worth a combined $8.54M — down 18% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LNAI positions and 1 closed out — a net gain of 6 holders — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $168K. The largest seller was Vanguard Group, cutting an estimated $1.42M.
- 39 institutional investors held Lunai Bioworks (LNAI) as of Q3 2020, up from 33 in Q2 2020.
- Funds reported $8.54M of Lunai Bioworks stock for Q3 2020, down 18% quarter-over-quarter.
- 7 funds opened new Lunai Bioworks positions in Q3 2020 and 1 closed out, a net change of +6 holders.
- The largest Lunai Bioworks buyer in Q3 2020 was Russell Investments Group, an estimated $168K added.
- The largest Lunai Bioworks seller in Q3 2020 was Vanguard Group, an estimated $1.42M sold.
Based on aggregated 13F filings for Q3 2020.